Novo Nordisk Fined Over Wegovy Deal With Falck
The Danish pharma company received a fine from the industry ethics board over a weight-loss collaboration.
2026年9月30日
/ DANGDI / DANGDI / DANGDI /Novo Nordisk faces a fine of 45,000 Danish kroner over its partnership with Falck.
The Ethical Board for the Pharmaceutical Industry issued the fine and a formal reprimand.
The ruling relates to a commercial weight-loss programme for patients using Wegovy.
Danish news outlet DR reported the decision from the independent board.
Novo Nordisk and Falck announced their cooperation earlier this year.
Source: The Copenhagen Post
